Medical Device News Magazine

Long-time Collaborators Botond Roska and José-Alain Sahel Win the Wolf Prize 2024 in the Field of Medicine

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Botond Roska and José-Alain Sahel have been awarded the Wolf Prize in Medicine for their pioneering work on restoring vision to blind patients using optogenetic therapy.

The Wolf Prize, considered one of the most prestigious international awards, recognizes outstanding achievements in various fields including medicine.

Botond Roska, Director at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and Professor at the University of Basel, and Sahel, Chair of Ophthalmology at the University of Pittsburgh School of Medicine and Chair of IOB’s Scientific Advisory Board, have collaborated since 2001. Their work focuses on optogenetic vision restoration, a technique that creates light-sensitive cells using genes derived from algae, to treat degenerative retinal diseases.

In 2021, they reported groundbreaking results from an early-stage clinical trial with blind retinitis pigmentosa patients. One patient who completed the full study protocol was able to detect and move objects placed before him within months of treatment. This work, which was done in collaboration with researchers from the Institut de la Vision in Paris, marked the first proof-of-concept for optogenetics in human disease. Despite initial scepticism, Roska and Sahel persevered, recognizing the potential of optogenetics for treating retinal diseases due to its mutation-independent approach and the accessibility of the eye’s optical system.

The collaboration between Roska, a basic scientist with an MD, and Sahel, an accomplished clinician and expert in translational research, has proven highly complementary. Their work represents a significant milestone in treating blinding conditions affecting millions worldwide, with promising results emerging from ongoing clinical trials. The Wolf Prize in Medicine acknowledges their exceptional contributions to the field of ophthalmology.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”